ArticleAnnals of translational medicine2022
Non-mass enhancement breast lesions: MRI findings and associations with malignancy.
Article in Annals of translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Meta-analysis of dynamic contrast enhancement and diffusion-weighted MRI for differentiation of benign from malignant non-mass enhancement breast lesions.Frontiers in oncology · 2024Pooled it
- Multiparametric MRI for non-mass enhancement breast lesions: a prospective diagnostic accuracy study.European radiology · 2026Article
- Second-Look Ultrasonography for Evaluating BIRADS 3 and 4 Non Mass-Enhancement: A Cross-Sectional Study.Health science reports · 2026Article
- Fine-tuned multimodal GPT-4o for generating diagnostic impressions in breast magnetic resonance imaging: insights into non-mass enhancement lesions.Quantitative imaging in medicine and surgery · 2026Article
- Dynamic curve type serves as an effective tool for the diagnosis of benign or malignant non-mass enhancements on breast MRI.Oncology letters · 2026Article
- PEM as an adjunct to MRI or CESM for characterizing non-mass enhancement: a retrospective two-arm diagnostic study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2026Article
- Whole-lesion histogram analysis of multi-model diffusion-weighted imaging for characterization and molecular classification of breast lesions.La Radiologia medica · 2026Article
- Dual-encoder 3D transformer-based U-Net with temporal attention for non-mass enhancement segmentation in breast dynamic contrast-enhanced MRI.Radiological physics and technology · 2026Article
- Magnetic resonance imaging findings of non-mass enhancements in the breast and their association with malignancy.Medicine · 2026Article
- Diagnostic performance of Kaiser score, ADC, and their combination for BI-RADS 4 breast lesions: subgroup and misclassification analysis.Frontiers in oncology · 2026Article
- Segmental Non-Mass Enhancement Features in Breast Magnetic Resonance Imaging: A Multicenter Retrospective Study of Histopathologic Correlations.Diagnostics (Basel, Switzerland) · 2025Article
- Histogram analysis of relaxometry from synthetic MRI for differentiation of breast BI-RADS 4 non-mass enhancement lesions.BMC medical imaging · 2025Article
- Multivariable model to predict breast cancer in non-mass enhancement lesions: a study on contrast-enhanced mammography.European radiology · 2025Article
- Correlation Between Pathological and MRI Radiological Tumor Responses to Neoadjuvant Chemotherapy in Non-Luminal Breast Cancer: A Single Institution Experience.Cancer reports (Hoboken, N.J.) · 2025Article
- An Updated Systematic Review and Meta-Analysis of Diagnostic Accuracy of Dynamic Contrast Enhancement and Diffusion-Weighted MRI in Differentiating Benign and Malignant Non-Mass Enhancement Lesions.Journal of clinical medicine · 2025Review
- Nonmass lesions on preoperative MRI in breast cancer patients: clinical implications and prognostic significance.Scientific reports · 2025Article
- Magnetic resonance imaging features and diagnostic value analysis of non-mass enhancement lesions of the breast.Quantitative imaging in medicine and surgery · 2025Article
- Characteristics of Non-mass Enhancement in Contrast-enhanced Breast MRI and Associations with Malignancy.Journal of Cancer · 2025Article
- DWI in the Differentiation of Malignant and Benign Breast Lesions Presenting with Non-Mass Enhancement on CE-MRI.Cancers · 2024Article
- Case report: Illustrating associated malignancies in Paget's disease using contrast-enhanced mammography.Frontiers in oncology · 2024Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Magnetic resonance imaging (MRI) is a multi-sequence imaging technique. Although MRI is the most sensitive method for detecting breast cancer, it is limited in evaluating the malignant possibility of non-mass enhanced (NME) breast lesions. It is also rarely reported whether MRI can further indicate the invasion of the lesions. In this article, we explore the differentiation of MRI characteristics between benign and malignant NME lesions and determine which features are associated with invasion. Methods: The MRI findings of 118 NME lesions were evaluated retrospectively to explore the characteristics of the benign and malignant NME lesions in different MRI sequences including dynamic contrast-enhanced (DCE) MRI and diffusion-weighted imaging (DWI). The difference of MRI findings between benign and malignant NME lesions were determined by Pearson χ Results: This study included 118 NME lesions (62 benign and 56 malignant) in 118 patients. We found a segmental distribution, clustered-ring enhancement, wash-out dynamic curve, and lower apparent diffusion coefficient (ADC) value (P=0.01, <0.001, 0.02, 0.001) were associated with malignancy. Wash-out dynamic curves, diffusion restriction on DWI, lower ADC values were more advantageous in distinguishing invasive NME cancer from benign lesions than ductal carcinoma Conclusions: MRI is a valuable way to identify malignant NME lesions and could predict the invasion of the lesions. Compared with carcinoma
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.